http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9422438-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6e32f0b6edccd065ac90c85de2290e0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc57aaaff2637972bd2ed8e60d6244f7 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-063 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06 |
| filingDate | 1993-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fb33a6a3c2ae9bfbd1ab66fc3a64ec9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_258cddb9096e927b80601552d34f53bf |
| publicationDate | 1994-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-9422438-A1 |
| titleOfInvention | Pharmaceutical composition for the treatment of certain viruses and autoimmune diseases and the procedure of its preparation |
| abstract | A new pharmaceutical composition and the procedure of its preparation are disclosed, useful in the treatment of AIDS of certain viruses and autoimmune diseases and formulated as an aqueous injectable, or orally administered solution. Four examples are given of the pharmaceutical composition according to the invention. Example I: the pharmaceutical composition is composed of the calcium and sodium double salt of ethylenediaminetetraacetic acid, associated with calcium gluconate, reduced glutathione and sodium metabisulfite, wherein the weight ratio of the ingredients ranges from 5-10.5 g to 0.2-2 g to 0.01-0.1 g to 0.01-0.2 g respectively per 100 ml of water. Example II: the calcium disodium salt of ethylenediaminetetraacetic acid associated with calcium gluconate and L-histidine wherein the weight ratio for the active ingredients ranges from 5-10.5 g to 0.3-1 g to 0.05-0.2 g respectively per 100 ml of water. Example III: the calcium and sodium salt of diethylenetriaminepentaacetic acid (DTPA Na3Ca) associated with calcium gluconate, L-cysteine hydrochloride and sodium metabisulfite, the association weight ratio of the ingredients is 5-10 g to 0.4-1 g to 0.03-0.15 g to 0.05-0.15 g respectively per 100 ml water. Example IV: the calcium disodium salt of ethylenediaminetetraacetic acid associated with calcium gluconate, L-cysteine hydrochloride and sodium metabisulfite, wherein the weight ratio of the four active ingredients ranges from 9-11 g to 0.4-0.8 g to 0.1-0.3 g to 0.1-0.3 g respectively per 100 ml of water. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007055388-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007055393-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19533477-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9606639-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19615461-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9606639-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19615461-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9857625-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8106020-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9857625-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9395376-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102707070-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8399417-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007055388-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8173605-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8420144-B2 |
| priorityDate | 1993-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 75.